Sign in
CompletedNo phase

Culturally Tailored Cannabis Use Disorder App

Key facts

Who runs it
University of Houston
Where
Houston, United StatesSee the site
Trial code
Status
Completed
People taking part
50 people enrolled
Started
14 Jun 2023
Ended
31 Jan 2024
Type of study
Interventional
Treatments tested
  • CT-MICART App
  • Control
Record updated
7 May 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • at least 18 years of age
  • identify as Black/African American
  • CUD per CUPIT-R
  • willing and able to complete study appointments
  • motivated to reduce cannabis (≥5 on a 10-point scale)
  • score ≥ 4 on the REALM-SF indicating ≥ 6th grade English literacy level (needed to use app)
  • report cannabis use to manage anxiety/stress in the past month

Who cannot take part

  • report of current or intended participation in a concurrent substance use treatment, including pharmacotherapy or psychotherapy for CUD not provided by researchers
  • legal mandate or substance misuse treatment
  • ongoing psychotherapy of any duration directed specifically toward the treatment of anxiety or depression
  • not being fluent in English
  • pregnant of planning to become pregnant within the next six months (assessed via self-report)

Where in United States

  • University of HoustonHouston, United States

About the trial

What the trial wants to find out

The present study aims to address disparities in cannabis use outcomes among African American/Black (hereby referred to as Black) adults with cannabis use disorder (CUD). The specific aims of this study are: (1) to develop a culturally adapted, mobile app for Black cannabis users (CT-MICART) using knowledge from the current research team, published literature, expert opinion, and feedback from the Community Research Advisory Board (CRAB), (2) to pilot test CT-MICART and (3) focus on analysis of data collected as part of Aim 2.

The group in the trial

  • CT-MICART AppTreatment being tested

    Participants in this arm will receive daily EMAs for 6 weeks.

    Treatment: CT-MICART App and Control

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Mobile App to Address CUD Among Black Adults
Publications
Record updated
7 May 2024